Picroside II Attenuates Airway Inflammation by Downregulating the Transcription Factor GATA3 and Th2-Related Cytokines in a Mouse Model of HDM-Induced Allergic Asthma

Abstract

Picroside II isolated from Pseudolysimachion rotundum var. subintegrum has been used as traditional medicine to treat inflammatory diseases. In this study, we assessed whether picroside II has inhibitory effects on airway inflammation in a mouse model of house dust mite (HDM)-induced asthma. In the HDM-induced asthmatic model, picroside II significantly reduced inflammatory cell counts in the bronchoalveolar lavage fluid (BALF), the levels of total immunoglobulin (Ig) E and HDM-specific IgE and IgG1 in serum, airway inflammation, and mucus hypersecretion in the lung tissues. ELISA analysis showed that picroside II down-regulated the levels of Th2-related cytokines (including IL-4, IL-5, and IL-13) and asthma-related mediators, but it up-regulated Th1-related cytokine, IFNγ in BALF. Picroside II also inhibited the expression of Th2 type cytokine genes and the transcription factor GATA3 in the lung tissues of HDM-induced mice. Finally, we demonstrated that picroside II significantly decreased the expression of GATA3 and Th2 cytokines in developing Th2 cells, consistent with in vivo results. Taken together, these results indicate that picroside II has protective effects on allergic asthma by reducing GATA3 expression and Th2 cytokine bias.

The Cell Research Trends of Asthma: A Stem Frequency Analysis of the Literature

“…However, it ceased to be the hot spot because of the continuous exploration of new treatments or drugs, such as Montelukast [ 89 ] and monoclonal antibodies [ 90 ]. During the past 20 years, the shared stem, “inhibitor,” indicated that as one type of a new drug for asthma, inhibitors such as histone deacetylase inhibitors [ 91 , 92 ] and tyrosine kinase inhibitors [ 93 ] were implicated in influencing gene expression of asthma-related cytokines [ 94 ], gaining importance.…”

Reduction of Asthmatic Parameters by Sea Hare Hydrolysates in a Mouse Model of Allergic Asthma

“…HSHH resulted in a reduction in Th2 cytokines. Suppressors of Th2 cytokines could not be overlooked in the development of anti-asthmatic compounds because excessive Th2 cytokines are a large risk factor for asthma [ 53 , 54 ]. The primary inflammatory lesion of asthma is accompanied by the accumulation of cluster of differentiation 4+ (CD4+) Th2 cells and Eos’s in the airway mucosa and its secretion of a series of cytokines, mostly IL-4, IL-13, IL-5, and IL-9.…”

Pantethine Down-Regulates Leukocyte Recruitment and Inflammatory Parameters in a Mouse Model of Allergic Airway Inflammation

“…The event was not limited to lymphocytes, as it involved all inflammatory cell types, including eosinophils, which are assumed to play a broad role in disease development [ 14 ]. Accordingly, levels of factors that play a critical role in the disease [ 15 , 16 ] were significantly reduced, as shown by lung levels of Th2 cytokines such as IL-4, IL-5, and IL-13, as well as circulating levels of LACK-specific IgE and IgG1. The protective effect of inhibiting the IgE allergic pathway has been demonstrated in patients with severe persistent asthma, using humanized mAb to IgE [ 17 ].…”